Logo-ipp

Immunopathol Persa. 2021;7(2): e31. doi: 10.34172/ipp.2021.31

Review

Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion

Nasrin Ghiasi 1 ORCID, Rohollah Valizadeh 2 ORCID, Mohammad Arabsorkhi 3 ORCID, Tahere Sadat Hoseyni 4, Korosh Esfandiari 4, Tella Sadighpour 5 * ORCID, Hamid Reza Jahantigh 6,7

Cited by CrossRef: 57

1- Khan Z, Ahmad U, Ualiyeva D, Amissah O, Khan A, Noor Z, Zaman N. Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?. Clinical Immunology Communications. 2022;2:1 [Crossref]
2- Hosseini R, Askari N. A review of neurological side effects of COVID-19 vaccination. Eur J Med Res. 2023;28(1) [Crossref]
3- Riazi A, Faghih Dinevari M, Abbasian S, Jabbaripour Sarmadian A. Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report. Clinical Case Reports. 2023;11(6) [Crossref]
4- Wijesekara P, Wang Y. A Mathematical Epidemiological Model (SEQIJRDS) to Recommend Public Health Interventions Related to COVID-19 in Sri Lanka. COVID. 2022;2(6):793 [Crossref]
5- Heidary M, Kaviar V, Shirani M, Ghanavati R, Motahar M, Sholeh M, Ghahramanpour H, Khoshnood S. A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. Front Microbiol. 2022;13 [Crossref]
6- Zahid M. Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study. Vaccines. 2021;9(11):1369 [Crossref]
7- Saravanan V, Chagaleti B, Narayanan P, Anandan V, Manoharan H, Anjana G, Peraman R, Namasivayam S, Kavisri M, Arockiaraj J, Muthu Kumaradoss K, Moovendhan M. Discovery and development of COVID‐19 vaccine from laboratory to clinic. Chem Biol Drug Des. 2024;103(1) [Crossref]
8- Khan S, Khan S, Haider F, Malik J, Khan F, Khan I, Ullah I, Zia M, Kousar S. The Burden of Omicron Variant in Pakistan: An Updated Review. COVID. 2022;2(10):1460 [Crossref]
9- Sznajder K, Kjerulff K, Wang M, Hwang W, Ramirez S, Gandhi C. Covid-19 vaccine acceptance and associated factors among pregnant women in Pennsylvania 2020. Preventive Medicine Reports. 2022;26:101713 [Crossref]
10- Letafati A, Eyvazzadeh N, Gharehkhani A, Khorshidian A, Chalabiani S, Soufiani E, Khakpoor N, Shamsodini B, Beheshti T, Bavili Olyaei R, Soleimani A, Melyani F, Hossein G. Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection. Biologicals. 2023;82:101668 [Crossref]
11- Sedaghat M, Karami B, Najafi F, Shadmani F, Rezaeian S. Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers. Vaccine. 2024;42(26):126424 [Crossref]
12- Nematshahi M, Soroosh D, Neamatshahi M, Attarian F, Rahimi F. Factors predicting readmission in patients with COVID-19. BMC Res Notes. 2021;14(1) [Crossref]
13- Ezati E, Barati M, Darabi F, Ezzati Rastegar K, Safarzadeh B, Morsali A. Evaluation of the effect of vaccination and its consequences in patients with COVID-19 in western Iran. Health Science Monitor. 2024;3(2):120 [Crossref]
14- Zare H, Rezapour H, Fereidouni A, Nikpour S, Mahmoudzadeh S, Royce S, Fereidouni M. Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers. Immun Ageing. 2022;19(1) [Crossref]
15- Ulyukin I, Rassokhin V, Sechin A, Orlova E. Neuromuscular and neuropsychiatric disorders in humans due to preventive vaccination against COVID-19 infection. VIČ-infekc immunosupr. 2024;16(3):25 [Crossref]
16- Assaid N, Arich S, Charoute H, Akarid K, Ezzikouri S, Maaroufi A, Sarih M. Anti-SARS-CoV-2 Antibody Responses 5 Months Post Complete Vaccination of Moroccan Healthcare Workers. Vaccines. 2022;10(3):465 [Crossref]
17- Bostanghadiri N, Ziaeefar P, Mofrad M, Yousefzadeh P, Hashemi A, Darban-Sarokhalil D, Muddassir Ali M. COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development. BioMed Research International. 2023;2023(1) [Crossref]
18- Pêgo A, Lima I, Gozzelino R. Addressing Inequality in the COVID-19 Pandemic in Africa: A Snapshot from Clinical Symptoms to Vaccine Distribution. COVID. 2024;4(2):170 [Crossref]
19- Ghasemi M, Khosravi S, Malekyan L, Faridi A, Abedi Gheshlaghi L, Sobhanipoor M, Isaei E. Side Effects of Sputnik V, Sinopharm, and AstraZeneca COVID-19 Vaccines among Healthcare Workers. J Occup Health Epidemiol. 2024;13(2):70 [Crossref]
20- Mazaheri M, Moazen J, Rezaei Z, Aghababaeian H, Mohebbi L, Eghtedari M, Nikjoo M, Shoush A, Hedayat Z. COVID-19 Vaccination in Adolescents: Side Effects and Symptomatic Reinfections. Arch Clin Infect Dis. 2023;18(6) [Crossref]
21- Ghelichi-Ghojogh M, Khezri R, Rezaei F, Aljalili S, Valizadeh R, Sadighpour T. Health inequality in COVID-19 vaccination coverage. Health Science Monitor. 2023;2(1):10 [Crossref]
22- Siahvoshi S, Movahed E, Ghods K. Common Side Effects of COVID-19 Vaccines Used in Iran: A Review. Ann Mil Health Sci Res. 2022;19(4) [Crossref]
23- Saadh M, Jaber S. Efficacy of COVID-19 vaccines. Microbial Pathogenesis. 2022;171:105729 [Crossref]
24- Elumalai K, Srinivasan S, Shanmugam A. Impact of COVID-19 vaccines on liver function: A state of the art and challenges for healthcare providers. Gastroenterology & Endoscopy. 2024;2(1):42 [Crossref]
25- Qamar N, Rukh G, Khan S. Vaccines for Covid‐19: An insight on their effectiveness and adverse effects. Journal of Medical Virology. 2022;94(8):3554 [Crossref]
26- Almufty H, Mamani M, Ali A, Merza M. COVID‐19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort study. Journal of Medical Virology. 2022;94(11):5244 [Crossref]
27- Teymoorzadeh M, Daneshfar N, Yazdanparast R, Okada H. Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats. PLoS ONE. 2023;18(5):e0284601 [Crossref]
28- Prospects of Vaccination Against COVID-19 and Road to DNA-based Vaccine: A Review. Sci Lett. 2022;10(1):1 [Crossref]
29- Moradi Hasan-Abad A, Arbabi M, Gilasi H, Motedayyen H. Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population. Int J Immunopathol Pharmacol. 2024;38 [Crossref]
30- Samanta S, Banerjee J, Das A, Das S, Ahmed R, Das S, Pal A, Ali K, Mukhopadhyay R, Giri B, Dash S. Enhancing Immunological Memory: Unveiling Booster Doses to Bolster Vaccine Efficacy Against Evolving SARS-CoV-2 Mutant Variants. Curr Microbiol. 2024;81(3) [Crossref]
31- Noh N, Karuppannan M. COVID-19 Vaccine Hesitancy and Self-reported Adverse Effects: A Narrative Review. MJMHS. 2023;19(s12):79 [Crossref]
32- Ito R, Maeda M, Takehara Y, Komori G, Nishi Y, Kondo K, Nagata T, Armijo Subieta F, Crespo G, Shoji H. An epidemiological evaluation of COVID-19 in La paz, Bolivia. Journal of Infection and Chemotherapy. 2023;29(3):333 [Crossref]
33- Chakraborty C, Bhattacharya M, Dhama K. SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic. Vaccines. 2023;11(3):682 [Crossref]
34- Kouchek M, Miri M, Aghakhani K, Memarian A. ABO blood group is related to the prevalence, severity, and mortality rate of COVID-19. Medicina Clínica Práctica. 2024;7(3):100442 [Crossref]
35- Akrami M, Hosamirudsari H, Faraji N, Behnush B, Goudarzi F, Hesari E, Akbarpour S, Najafi A, Nateghi S. Sputnik V vaccine-related complications and its impression on inflammatory biomarkers in healthcare providers. Indian Journal of Medical Microbiology. 2023;43:79 [Crossref]
36- Zare Marzouni H, Rahbar M, Seddighi N, Nabizadeh M, Meidaninikjeh S, Sabouni N. Antibody Therapy for COVID-19: Categories, Pros, and Cons. Viral Immunology. 2022;35(8):517 [Crossref]
37- Ammar A, Shah J, Khan W, Kumar R, Shaikh A, Ali F, Zehra M, Sial J, Saghir T, Rehman Z. COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency. 2022; [Crossref]
38- Pouresmaeil M, Azizi-Dargahlou S. Factors involved in heterologous expression of proteins in E. coli host. Arch Microbiol. 2023;205(5) [Crossref]
39- Sadeghi S, Kalantari Y, Shokri S, Fallahpour M, Nafissi N, Goodarzi A, Valizadeh R. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis. Journal of Clinical Virology. 2022;153:105196 [Crossref]
40- Samir A, Altarawy D, Sweed R, Abdel-Kerim A. "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA). Egypt J Radiol Nucl Med. 2023;54(1) [Crossref]
41- Teli A, Rathore P, Kumar R, Alam M. Vaccine equity and access: A comparative assessment of Covaxin, Covishield, and Sputnik V.. IJPP. 2023;10(2):76 [Crossref]
42- Ghildiyal T, Rai N, Mishra Rawat J, Singh M, Anand J, Pant G, Kumar G, Shidiki A, Melgaço J. Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants. Journal of Immunology Research. 2024;2024:1 [Crossref]
43- Sayed S, El-Khatib M, Abdelghaffar M, Metwally F, ElSary A, Daker L. The pattern of neurological disorders requiring hospitalization during the COVID-19 era: an experience from Fayoum University Hospital, Egypt. Egypt J Neurol Psychiatry Neurosurg. 2024;60(1) [Crossref]
44- Polatoğlu I, Oncu‐Oner T, Dalman I, Ozdogan S. COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies. MedComm. 2023;4(2) [Crossref]
45- Joudi M, Moradi Binabaj M, Porouhan P, PeyroShabany B, Tabasi M, Fazilat-Panah D, Khajeh M, Mehrabian A, Dehghani M, Welsh J, Keykhosravi B, Akbari Yazdi A, Ariamanesh M, Ghasemi A, Ferns G, Javadinia S. A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?. Front Endocrinol. 2022;13 [Crossref]
46- Boshra M, Hussein R, Mohsen M, Elberry A, Altyar A, Tammam M, Sarhan R. A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca. Vaccines. 2022;10(2):292 [Crossref]
47- Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol Biol Lett. 2022;27(1) [Crossref]
48- Srivastava S, He F, Huang Y, Niu M, Adholeya A, Peng W, Saki M. A Brief Review on Medicinal Plants-At-Arms against COVID-19. Interdisciplinary Perspectives on Infectious Diseases. 2023;2023:1 [Crossref]
49- Zheng K, Chong A, Mentzer A. How could our genetics impact COVID-19 vaccine response?. Expert Review of Clinical Immunology. 2024;20(9):1027 [Crossref]
50- Zahid R, Riaz S. Systematic Review of the SARS-CoV-2 Viral Vector Vaccine AstraZeneca (Azd1222). BioSci Rev. 2022;4(2):1 [Crossref]
51- Suhana P, Kusum L, Shruti J, Sreekanth G, Bijukumar D, Shaji Kumar R, Muraleedharan K, Kaushik S. Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the Pathanamthitta District of Kerala. JMIR Res Protoc. 2023;12:e48479 [Crossref]
52- Alam O, Ahmad M, Qureshi M, Gul M, Khan N, Samad A, Khan Z, Atiq S, Iqbal A, Ullah A. Unraveling COVID-19: A Global Health Crisis and Ongoing Research. FBT. 2023;:10 [Crossref]
53- Tavakoli N, Nafissi N, Shokri S, Fallahpour M, Soleimani S, Riahi T, Kalantari S, Javan A, Goodarzi A, Valizadeh R. Pediatric and adolescent COVID‐19 vaccination side effects: A retrospective cohort study of the Iranian teenage group in 2021. Journal of Medical Virology. 2022;94(10):4890 [Crossref]
54- Yaamika H, Muralidas D, Elumalai K. Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases. Journal of Taibah University Medical Sciences. 2023;18(6):1646 [Crossref]
55- Firouzabadi N, Ghasemiyeh P, Moradishooli F, Mohammadi-Samani S. Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2. International Immunopharmacology. 2023;117:109968 [Crossref]
56- Zamani B, Moradi Hasan‐Abad A, Piroozmand A, Dehghani M, Arfaatabar M, Motedayyen H. Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort. Immunity Inflam & Disease. 2023;11(5) [Crossref]
57- Qutaiba Allela O. Evaluation of COVID-19 Vaccination Status among University’s Students, Academic and Nonacademic Staff in Mosul, Iraq. Med J Babylon. 2024;21(Suppl 2):S171 [Crossref]
58- Adnan N, Haq M, Akter S, Sajal S, Islam M, Mou T, Jamiruddin M, Jubyda F, Islam M, Tuli J, Liza S, Hossain S, Islam Z, Ahmed S, Khandker S, Hossain R, Ahmed M, Khondoker M, Azmuda N, Parvez M. Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort. Vaccines. 2024;12(5):482 [Crossref]